There was no significant difference in the age of patients with unmethylated SOCS-1 (65.8 years; range, 38–85 years) and methylated SOCS-1 (65.1 years; range, 46–83 years) in their primary pancreatic cancers. The gene discussed is SOCS1; the disease is pancreatic neoplasm.